Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael ...

Robert W. Baird analyst Jeff Johnson reiterated a Buy rating on Henry Schein (HSIC – Research Report) on November 5 and set a price ...

Henry Schein is a Fortune 500 company and one of the global leaders in its industry, providing healthcare solutions, as well as the distribution of medical, dental, and veterinary supplies.

NEW YORK (Reuters) -Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.5, a high estimate of $82.00, ...

Henry Schein Inc. closed $12.62 short of its 52-week high ($82.63), which the company reached on February 27th.

Analysts' ratings for Henry ... Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products ...

We have also had multiple successes with customers that have switched to Henry Schein for their merchandise and equipment purchases as a result of our differentiated offering and the excellent ...